Modelling biopharmaceutical manufacture: Design and implementation of SimBiopharma

被引:39
作者
Farid, Suzanne S.
Washbrook, John
Titchener-Hooker, Nigel J.
机构
[1] UCL, Adv Ctr Biochem Engn, Dept Biochem Engn, London WC1E 7JE, England
[2] UCL, Dept Comp Sci, London WC1E 6BT, England
基金
英国生物技术与生命科学研究理事会;
关键词
object-oriented; decision-support tool; computer-aided simulation; biopharmaceutical batch manufacture; costs; uncertainty;
D O I
10.1016/j.compchemeng.2006.10.020
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
This paper presents the implementation of a conceptual framework, for modelling a biopharmaceutical manufacturing plant, into a prototype decision-support tool, SimBiopharma. The tool's scope covers the ability to evaluate manufacturing alternatives in terms of cost, time, yield, resource utilisation and risk. Incorporating uncertainty means that investment appraisal can be based on both the expected outputs and the likelihood of achieving them. A hierarchical approach to represent the key activities in a manufacturing process is introduced. Emphasis is placed on how a closer integration of bioprocess and business process modelling can be achieved by capturing common information in an object-oriented environment, G2 (Gensym Corporation, Cambridge, MA). The key features of SimBIOPHARMA are highlighted; these include interactive graphics, task-oriented representation and dynamic simulation which create a much more flexible environment for modelling processes. Examples of typical outputs generated by SimBIOPHARMA, when addressing the impact of manufacturing options on strategic operational and financial indicators, are given. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1141 / 1158
页数:18
相关论文
共 54 条
[1]  
ATKINSON B, 1991, BIOCH ENG BIOTECHNOL, pCH19
[2]  
Banks J, 1998, HANDBOOK OF SIMULATION, P3
[3]   Process model and recipe structure, the conceptual design for a flexible batch plant [J].
Bastiaan, HK .
ISA TRANSACTIONS, 1997, 36 (04) :249-255
[4]  
Bernstein DF, 2000, DRUG INF J, V34, P909, DOI 10.1177/009286150003400327
[5]   A process systems engineering view of biochemical process operations [J].
Bogle, IDL ;
Cockshott, AR ;
Bulmer, M ;
Thornhill, N ;
Gregory, M ;
Dehghani, M .
COMPUTERS & CHEMICAL ENGINEERING, 1996, 20 (6-7) :943-949
[6]  
BYROM D, 2000, PHARM TECHNOLOGY EUR, V12, P52
[7]   Therapeutic antibody expression technology [J].
Chadd, HE ;
Chamow, SM .
CURRENT OPINION IN BIOTECHNOLOGY, 2001, 12 (02) :188-194
[8]  
Clemento A, 1999, DRUG INF J, V33, P699, DOI 10.1177/009286159903300306
[9]  
COPMANN T, 2001, BIOPHARM, P14
[10]  
CROWL TE, 1997, ISA TECH EXP TECHN U, V1, P131